We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

Genetically Encoded Luciferase Biosensors for Screening Potentially Difficult Targets...

Genetically Encoded Luciferase Biosensors for Screening Potentially Difficult Targets Scientific Poster



Frank Fan, Brock Binkowski, Susan Wigdal, Braeden Butler, Ken Lewis, Pete Stecha, Keith Wood
Promega Corporation, 2800 Woods Hollow Rd., Madison, WI 53711

Many potentially druggable targets have proven to be difficult to adapt to many screening programs, especially as cell-based assays. In recent years we have developed new bioluminescent-based assays to address such challenges. Bioluminescent assays are uniquely suited for high-throughput screening due to their inherent high sensitivity, wide dynamic range and low susceptibility to compound interference. In this report, we present a new biosensor technology to address two popular targets in pharmaceutical screening: Proteases and GPCRs.

Document Icon Download the poster PDF (185kb)

  • Part# PS067
  • Printed in USA.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.